A commitment to excellence
Merz North America is a specialty healthcare company that develops and commercializes innovative treatment solutions in aesthetics, dermatology and neurosciences in the U.S. and Canada. Our ambition is to become a recognized leader in the treatment of movement disorders, and in aesthetics and dermatology. Our future is promising, and we are committed to advancing new therapeutic options and improving patients’ lives.
For more than 100 years, the development of our products has been based on Merz`s commitment to providing innovative medical approaches that earn trust of patients, physicians and partners worldwide. Globally, the companies of Merz Pharma Group are focused on medications for treating neurological and psychiatric illnesses, and they have assumed a leading role in the field of Alzheimer’s disease research. Founded in 1908, Merz Pharma Group is a privately owned company headquartered in Frankfurt, Germany.
Meet our North America leadership team
President and CEO
Vice President US Dermatology
President and General Manager
Merz Pharma Canada Ltd.
Robert W. Burgess, CPA
Interim CFO and Vice President Administration
Katrina Church, JD
Chief Compliance Officer
Bill Edwards, JD
Vice President, and Secretary
Senior Vice President Technical Operations
Bhushan Hardas, MD, MBA
Vice President & US Head of Research & Development
Head of Global Research & Development, Dermatology
Senior Director Commercial Excellence and North American Strategic Implementation
Jon Parrish, PhD
Director Commercial Development & Planning
Brian Pilcher, PhD
Stefan Schacht, PhD
US Strategic Sourcing, IT, and Corporate Alignment